Work Here?
Cell Signaling Technology
Work Here?
Antibody development and validated research tools
Cell Signaling Technology
Work Here?
Antibody development and validated research tools
About Cell Signaling Technology
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Danvers, Massachusetts
Founded
1999
Overview
Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.
Simplify's Take
What believers are saying
- Cell signaling market grows to $7.11 billion by 2030 at 7.3% CAGR.
- Bio-Techne adds Simple Western validation to CST antibodies in 2023.
- CST invests $17.5M in Manchester property in July 2022 for expansion.
What critics are saying
- Leveragen nanobodies displace CST monoclonal antibodies in 12-24 months.
- Lunaphore scales single B cell screening, eroding CST revenue in 12-18 months.
- Visiopharm dependency fails if Indica Labs captures market in 18-36 months.
What makes Cell Signaling Technology unique
- CST launches SignalStar Multiplex IHC for 8-plex amplification in two days.
- CST partners with Visiopharm to integrate SignalStar with Phenoplex software.
- CST expands chimeric monoclonal antibodies to mouse, horse, and feline species.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Tuition Reimbursement
Unlimited Paid Time Off
Parental Leave
Employee Assistance Program
Professional Development Budget
Company News
Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.
Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!
Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.
According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.
Cell Signaling Technology (CST) , a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.
Cell Signaling Technology is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Cell Signaling Technology
Industries
Biotechnology
Healthcare
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Danvers, Massachusetts
Founded
1999
Cell Signaling Technology is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today